Journal article
Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: Missing links between depression, obesity and type 2 diabetes?
A Slyepchenko, M Maes, R Machado-Vieira, G Anderson, M Solmik, Y Sanz, M Berk, CA Köhlerp, AF Carvalhop
Current Pharmaceutical Design | BENTHAM SCIENCE PUBL LTD | Published : 2016
Abstract
The comorbid prevalence of major depressive disorder (MDD) with obesity and type II diabetes mellitus reflects the existence of a subset of individuals with a complex common pathophysiology and overlapping risk factors. Such comorbid disease presentations imply a number of difficulties, including: decreased treatment responsivity and adherence; altered glycemic control and increased risk of wider medical complications. A number of factors link MDD to metabolic-associated disorders, including: higher rates of shared risk factors such as poor diet and physical inactivity and biological elements including increased inflammation; insulin resistance; oxidative and nitrosative stress; and mitochon..
View full abstractGrants
Awarded by Seventh Framework Programme
Funding Acknowledgements
YS contribution is supported by the European Union's Seventh Framework Program under the grant agreement no 613979 (MyNewGut) and the Spanish Ministry of Economy and Competitiveness (MINECO, Spain) grant AGL2014-52101-P. MB is supported by a NHMRC Senior Principal Research Fellowship 1059660. AFC is supported by a research fellowship award from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; Brazil).